<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="review-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id>
<journal-title>Frontiers in Physiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Physiol.</abbrev-journal-title>
<issn pub-type="epub">1664-042X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1008364</article-id>
<article-id pub-id-type="doi">10.3389/fphys.2022.1008364</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Physiology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Circular RNAs: Emerging players in the pathogenesis of keloid</article-title>
<alt-title alt-title-type="left-running-head">Yu et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphys.2022.1008364">10.3389/fphys.2022.1008364</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yu</surname>
<given-names>Xin</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Xueqing</given-names>
</name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Li</surname>
<given-names>Linfeng</given-names>
</name>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1332891/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gao</surname>
<given-names>Guangcheng</given-names>
</name>
</contrib>
</contrib-group>
<aff>
<institution>Department of Dermatology</institution>, <institution>Beijing Friendship Hospital</institution>, <institution>Capital Medical University</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1677394/overview">Lifeng Lao</ext-link>, Shanghai Jiao Tong University, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1565860/overview">Cheng Huang</ext-link>, China-Japan Friendship Hospital, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1419139/overview">Derong Xu</ext-link>, Qingdao University, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Linfeng Li, <email>fgr3r4@yeah.net</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Cell Physiology, a section of the journal Frontiers in Physiology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>09</day>
<month>11</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>1008364</elocation-id>
<history>
<date date-type="received">
<day>31</day>
<month>07</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>09</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Yu, Zhu, Li and Gao.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Yu, Zhu, Li and Gao</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Circular RNAs (circRNAs) are a new type of non-coding RNAs originating from precursor messenger RNAs. Recent research has confirmed that circRNAs play a significant role in various biological and pathological processes, including cell viability, migration, and apoptosis. Emerging studies have demonstrated that the deregulated circRNA&#x2013;miRNA&#x2013;mRNA interaction network plays a key role in the development of many diseases. Increasing evidence has highlighted the role of ncRNAs (mainly miRNAs and lncRNAs) in the pathogenesis of keloids. Recently, several publications also indicated that circRNAs contribute to keloid development. The discovery of circRNAs changed the current understanding of the biology of keloids It is crucial to elucidate a circRNA&#x2013;miRNA&#x2013;mRNA network to understand the pathological mechanism of keloids. In the present review, we summarize the aberrant expression of regulatory roles of circRNAs in keloids. We discuss the potential clinical application of circRNAs in the diagnosis and treatment of keloids.</p>
</abstract>
<kwd-group>
<kwd>circular RNAs</kwd>
<kwd>circRNAs</kwd>
<kwd>keloid</kwd>
<kwd>miRNA</kwd>
<kwd>mRNA</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Keloids are pathological scars caused by skin injury and irritation. These are benign skin tumors characterized by hyperproliferation of fibroblasts and excessive deposition of collagen fibers (<xref ref-type="bibr" rid="B16">Limandjaja et al., 2020</xref>). Keloids can extend beyond the area of injury and invade the adjacent normal skin (<xref ref-type="bibr" rid="B28">Tan et al., 2019</xref>). Keloids significantly reduce people&#x2019;s life quality by causing esthetic deformity, pruritus, hyperesthesia, and pain (<xref ref-type="bibr" rid="B22">Olaitan, 2009</xref>). Conventional treatment ways, consisting of surgical excision, cryotherapy, topical steroids, and laser therapy, remain unsatisfactory, and relapse is common (<xref ref-type="bibr" rid="B24">Park et al., 2014</xref>; <xref ref-type="bibr" rid="B2">Berman et al., 2017</xref>; <xref ref-type="bibr" rid="B7">Ekstein et al., 2021</xref>). It is urgent to understand the mechanism underlying keloid formation for better treatment approaches.</p>
<p>Circular RNAs (circRNAs) are a new type of non-coding RNAs originating from precursor messenger RNAs. Different from linear RNA, circRNAs are single-stranded RNAs that form a closed loop. CircRNAs lack 5&#x2032; and 3&#x2019; ends, which makes them more stable (<xref ref-type="bibr" rid="B11">Jeck et al., 2013</xref>; <xref ref-type="bibr" rid="B13">Kristensen et al., 2019</xref>). Since circRNAs were first discovered in plant viroids in 1976, thousands of circRNAs across species have been identified (<xref ref-type="bibr" rid="B26">Sanger et al., 1976</xref>; <xref ref-type="bibr" rid="B29">Vo et al., 2019</xref>). CircRNAs were considered the byproduct of wrong splicing for a long time. Recent research has confirmed that circRNAs play a significant role in various biological and pathological processes, including cell viability, migration, and apoptosis (<xref ref-type="bibr" rid="B21">Memczak et al., 2013</xref>; <xref ref-type="bibr" rid="B6">Di Timoteo et al., 2020</xref>). CircRNAs exert their biological functions at the post-transcriptional level, including in transcription and splicing, interfering with miRNA activities or signaling pathways, and serving as translation templates (<xref ref-type="bibr" rid="B4">Chen, 2020</xref>). In particular, circRNAs contain various binding sites for miRNAs and absorb miRNAs like a sponge, serving as competitive endogenous RNAs (ceRNAs) or miRNA sponges (<xref ref-type="bibr" rid="B21">Memczak et al., 2013</xref>). Emerging studies have demonstrated that the deregulated circRNA&#x2013;miRNA&#x2013;mRNA interaction network plays a key role in the development of many diseases (<xref ref-type="bibr" rid="B15">Liang et al., 2020</xref>; <xref ref-type="bibr" rid="B25">Sakshi et al., 2021</xref>).</p>
<p>Increasing evidence has highlighted the role of ncRNAs (mainly miRNAs and lncRNAs) in the pathogenesis of keloids (<xref ref-type="bibr" rid="B1">Babalola et al., 2013</xref>). Recently, several publications also indicated that circRNAs contribute to keloid development. The discovery of circRNAs changed the current understanding of the biology of keloids. It is crucial to elucidate a circRNA&#x2013;miRNA&#x2013;mRNA network to understand the pathological mechanism of keloids. In the present review, we summarize the aberrant expression of regulatory roles of circRNAs in keloids. We discuss the potential clinical application of circRNAs in the diagnosis and treatment of keloid.</p>
</sec>
<sec id="s2">
<title>The etiology of keloids</title>
<p>Genetic, epigenetic, and environmental factors are crucial in molecular pathogenesis underlying keloid formation (<xref ref-type="bibr" rid="B10">He et al., 2017</xref>). The inheritance pattern of keloids may follow autosomal dominance with incomplete penetrance. In addition, keloids tend to be polygenic, not following a simple Mendelian monogenic manner. Individuals with dark skin color show an increased prevalence of keloids with an estimated incidence of 4%&#x2013;16%, 15 times higher than in Caucasian populations. NEDD4 was proven to be a candidate gene in Chinese Han and Japanese populations (<xref ref-type="bibr" rid="B8">Fujita et al., 2019</xref>). Epigenetic modifications are composed of DNA methylations, histone modifications, and non-coding RNA regulations. Non-coding RNAs are mainly composed of three types, microRNAs&#x2014;miRNAs, long non-coding RNAs&#x2014;lncRNAs, and circular RNAs&#x2014;circRNAs. Emerging research showed that epigenetics plays a crucial role in the molecular pathogenesis of keloids. Epigenetic modification is considered to be an important regulator in the initial and sustained activation of keloid fibroblasts (<xref ref-type="bibr" rid="B20">Lv et al., 2020</xref>).</p>
</sec>
<sec id="s3">
<title>CircRNA expression profiles in keloids</title>
<p>High-throughput sequencing and gene microarray have demonstrated aberrant expression profiles of circRNAs in keloid tissue and fibroblasts (<xref ref-type="table" rid="T1">Table 1</xref>). The altered expression profiles of circRNAs in keloid tissue may contribute to the etiology and pathophysiology of keloids by impacting signaling pathways relevant to the scaring process.</p>
<table-wrap id="T1" position="float">
<label>TABLE1</label>
<caption>
<p>Expression and function of dysfunctional circRNA in keloids.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">CircRNAs</th>
<th align="left">Expression</th>
<th align="left">Functional</th>
<th align="left">Possible mechanism</th>
<th align="left">Ref</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">
<bold>CircCOL5A1</bold>
</td>
<td align="left">Up</td>
<td align="left">Promoted HKF proliferation, migration, invasion, and ECM production. Inhibited HKF apoptosis</td>
<td align="left">miR-877-5p/EGR1</td>
<td align="left">24, 25</td>
</tr>
<tr>
<td align="left">
<bold>CircSLC8A1</bold>
</td>
<td align="left">Down</td>
<td align="left">Inhibited HKF proliferation, migration, and ECM deposition. Promoted HKF apoptosis</td>
<td align="left">miR-181a-5p/HIF1AN</td>
<td align="left">34</td>
</tr>
<tr>
<td align="left">
<bold>circ_0043688</bold>
</td>
<td align="left">Up</td>
<td align="left">Promoted HKF proliferation, migration, and invasion. Inhibited HKF apoptosis</td>
<td align="left">miR-145-5p/FGF2</td>
<td align="left">26</td>
</tr>
<tr>
<td align="left">
<bold>CircPDE7B</bold>
</td>
<td align="left">Up</td>
<td align="left">Promoted HKF proliferation, migration, and invasion. Inhibited HKF apoptosis</td>
<td align="left">miR-661/FGF2</td>
<td align="left">27</td>
</tr>
<tr>
<td align="left">
<bold>circ_101,238</bold>
</td>
<td align="left">Up</td>
<td align="left">Promoted HKF proliferation. Inhibited HKF apoptosis</td>
<td align="left">miR-138-5p/CDK6</td>
<td align="left">28</td>
</tr>
<tr>
<td align="left">
<bold>Circ_0008450</bold>
</td>
<td align="left">Up</td>
<td align="left">Inhibited human keratinized epithelial cell proliferation, migration, and EMT process. Promoted HKF apoptosis</td>
<td align="left">Runx3 tTGF-&#x3b2;/Smad</td>
<td align="left">31</td>
</tr>
<tr>
<td align="left">
<bold>circNRIP1</bold>
</td>
<td align="left">Up</td>
<td align="left">Promoted HKF proliferation and ECM production. Inhibited HKF apoptosis</td>
<td align="left">FXR1-mediated upregulation of miR-503-3p and miR-503-5p</td>
<td align="left">32</td>
</tr>
<tr>
<td align="left">
<bold>circPTPN12</bold>
</td>
<td align="left">Down</td>
<td align="left">Inhibited HKF proliferation, migration, and invasion. Promoted HKF apoptosis</td>
<td align="left">miR-21-5p/Wnt</td>
<td align="left">35</td>
</tr>
<tr>
<td align="left">
<bold>circ_0057452</bold>
</td>
<td align="left">Up</td>
<td align="left">Promoted HKF viability, proliferation, and migration. Inhibited HKF apoptosis</td>
<td align="left">miR-1225-3p/AF4/FMR2</td>
<td align="left">33</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>In a high-throughput sequencing research, Zhang et al. identified 411 differentially expressed (DE) circRNAs performed in three HKFs and normal dermal fibroblasts, with 206 circRNAs upregulated and 205 circRNAs downregulated. Bioinformatics analyses showed that 411 DE circRNAs mainly participated in cell apoptosis and focal adhesion processes, as well as PI3K-Akt, Rap1, and metabolic signaling pathways (<xref ref-type="bibr" rid="B36">Zhang et al., 2020a</xref>). Shi et al. used a circRNA microarray assay to determine circRNA expression in keloid tissue compared with paired normal skin tissue. They showed that 52 circRNAs were upregulated and 24 downregulated in keloids (<xref ref-type="bibr" rid="B27">Shi et al., 2020</xref>). In addition, further analysis found that circRNAs could interact with miR-29a, miR-23a-5p, and miR-1976 (<xref ref-type="bibr" rid="B27">Shi et al., 2020</xref>). Wang et al. performed high-throughput sequencing research in keloid tissue compared with normal skin tissue. Among 154 DE circRNAs, 81 circRNAs were upregulated and 73 circRNAs were downregulated (<xref ref-type="bibr" rid="B31">Wang et al., 2019</xref>). Li et al. performed high-throughput sequencing and showed that circRNAs might act as ceRNAs in the development of human hypertrophic scars (<xref ref-type="bibr" rid="B14">Li et al., 2018</xref>). Pang et al. performed microarray technology in four patient-derived keloid dermal fibroblasts (KDFs) compared with normal dermal fibroblasts (NDFs) (<xref ref-type="bibr" rid="B23">Pang et al., 2022</xref>). They detected a total of 327 DE circRNAs, with 195 upregulated and 132 downregulated circRNAs. The DE circRNAs were mainly enriched in cell function of the cytoskeleton, tight junctions, axonal guidance, and morphogenesis of the epithelium.</p>
</sec>
<sec id="s4">
<title>Mechanisms of circRNAs in keloids</title>
<p>Myofibroblasts derived from quiescent resident skin fibroblasts are the principal cell type responsible for extracellular matrix (ECM) accumulation. The imbalance between fibroblast proliferation and apoptosis is the cytological basis for the continuous proliferation of keloids, and it highlights the epigenetic contribution to keloid formation by modulating the balance between fibroblast proliferation and apoptosis.</p>
<sec id="s4-1">
<title>Keloid-promoting circRNAs</title>
<p>Lv et al. showed that circCOL5A1 was upregulated in keloid tissues and HKFs. Silencing of circCOL5A1 inhibited HKF proliferation, migration, and ECM deposition and promoted the rate of apoptosis. Moreover, circCOL5A1 sponges miR-7-5p to release Epac1 through the PI3K/Akt signaling pathway (<xref ref-type="bibr" rid="B19">Lv et al., 2021</xref>). Similarly, Jiao et al. showed that circCOL5A1 expression is obviously higher in keloid tissues and HKFs. CircCOL5A1 knockdown hindered HKF proliferation, invasion migration, and ECM deposition, while promoting the rate of cell apoptosis. Moreover, circCOL5A1 could upregulate the expression level of EGR1 <italic>via</italic> sponging miR-877&#x2013;5p (<xref ref-type="bibr" rid="B12">Jiao et al., 2022</xref>). Liu et al. found increased hsa_circ_0043688 and FGF2 and decreased miR-145-5p in human keloid samples and HKFs using RT-qPCR. Functional analysis showed that silencing of hsa_circ_0043688 repressed HKF proliferation, invasion, and migration and promoted apoptosis. Collectively, hsa_circ_0043688 modulated keloid progression <italic>via</italic> miR-145-5p/FGF2 (<xref ref-type="bibr" rid="B18">Liu et al., 2022a</xref>). CircPDE7B was highly expressed in keloid samples and HKFs. High circPDE7B accelerates HKF proliferation, migration, and invasion and hindered the rate of apoptosis. Moreover, circPDE7B functioned as a ceRNA for miR-661. The circPDE7B/miR-661/FGF2 ceRNA regulatory axis plays crucial roles in the pathogenesis of keloids (<xref ref-type="bibr" rid="B32">Wu et al., 2022</xref>). YANG et al. showed that circ_101,238 was significantly increased in keloid samples. Circ_101,238 was proven to sponge miR-138-5p, with CDK6 as a target. Transfection with sh-circ_101,238 inhibited HKF proliferation, while promoting apoptosis <italic>via</italic> regulating the miR-138-5p/CDK6 pathway (<xref ref-type="bibr" rid="B33">Yang et al., 2020</xref>). Runt-related transcription factors (Runx) play critical roles in the development and cancers (<xref ref-type="bibr" rid="B5">Date and Ito, 2020</xref>). Knockdown of circ_0008450 may reduce cell proliferation, migration, and EMT process of human keratinized epithelial cells and promoted apoptosis through increasing Runx3 and repressing the TGF-&#x3b2;/Smad signal pathway (<xref ref-type="bibr" rid="B3">Chen et al., 2020</xref>). The TGF-&#x3b2;/Smad signaling pathway is the most crucial pathway involved in the excessive production of collagen in the fibroblasts and myofibroblasts (<xref ref-type="bibr" rid="B35">Zhang et al., 2020b</xref>). WANG et al. demonstrated circNRIP1 was higher in keloid tissue than in adjacent skin tissue. Absence of circNRIP1 inhibited the proliferation and ECM-associated protein production while increasing apoptosis in HKFs. CircNRIP1 maintained FXR1 stability by inhibiting ubiquitination and degradation of FXR1, which increased the expression of miR-503-3p and miR-503-5p. In summary, circNRIP1 contributes to keloid development <italic>via</italic> FXR1-mediated upregulation of miR-503-3p and miR-503-5p (<xref ref-type="bibr" rid="B30">Wang et al., 2021</xref>). Gao et al. demonstrated that hsa_circ_0057452 and AFF4 are remarkably higher in keloids than in matched normal skin tissues. Hsa_circ_0057452 knockdown suppressed cell proliferation, viability, and migration, while accelerating the rate of apoptosis of HKFs. MiR-1225-3p is downregulated and showed a reverse effect on HKF function. Collectively, hsa_circ_0057452 regulates AFF4 and promotes keloid formation by sponging miR-1225-3p (<xref ref-type="bibr" rid="B9">Gao et al., 2022</xref>). Zhu et al. showed that circ_005745 induced keloid progression <italic>via</italic> upregulating GAB1 (<xref ref-type="bibr" rid="B37">Zhu et al., 2022</xref>).</p>
</sec>
<sec id="s4-2">
<title>Keloid suppressor circRNAs</title>
<p>Yuan et al. showed that the level of circSLC8A1 declined in keloid tissues and HKFs. Overexpression of circSLC8A1 inhibited cell proliferation, migration, and ECM production and elevated cell apoptosis of HKFs. MiR-181a-5p is a direct sponging target of circSLC8A1, and HIF1AN was the downstream effect factor of miR-181a-5p. Taken together, circSLC8A1 inhibited keloid progression by regulating the miR-181a-5p/HIF1AN axis (<xref ref-type="bibr" rid="B34">Yuan et al., 2022</xref>). CircPTPN12 expression was downregulated in keloid tissue compared with the adjacent normal skin. Silencing of circPTPN12 accelerated HKF proliferation, migration, and invasion and suppressed apoptosis. CircPTPN12 could sponge miR-21-5p, while SMAD7 was the downstream effect factor of miR-21-5p. MiR-21-5p was a direct target of circPTPN12. In summary, silencing of circPTPN12 promotes keloid formation by activating the Wnt pathway sponging miR-21-5p (<xref ref-type="bibr" rid="B17">Liu et al., 2022b</xref>) (<xref ref-type="fig" rid="F1">Figure 1</xref> and <xref ref-type="table" rid="T1">Table 1</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>CircRNAs regulated gene expression <italic>via</italic> sponging miRNAs and played crucial roles in keloid development.</p>
</caption>
<graphic xlink:href="fphys-13-1008364-g001.tif"/>
</fig>
</sec>
</sec>
<sec id="s5">
<title>Conclusion and future perspective</title>
<p>Some circRNAs are profibrotic and their upregulation contributed to the development of keloids. Those profibrotic circRNAs include circCOL5A1&#x3001;circ_0043688&#x3001;circPDE7B&#x3001;circ_101,238&#x3001;circ_0008450&#x3001;circNRIP1, and circ_0057452. However, some circRNAs are anti-fibrotic and their reduction inhibits the development of keloids. Those anti-fibrotic circRNAs include circSLC8A1 and circPTPN12. Gain- and loss-of-function studies have proven that deregulated circRNAs may regulate the processes underlying keloid formation and development.</p>
<p>CircRNAs are expected to be a potential diagnostic and therapeutic target in the management of keloids. For example, si-circCOL5A1 inhibited the growth and ECM deposition of keloids in the skin of nude mice (<xref ref-type="bibr" rid="B19">Lv et al., 2021</xref>). Further investigation into keloid-related circRNAs is needed to identify more effective prophylactic and clinical treatment strategies for keloids.</p>
</sec>
</body>
<back>
<sec id="s6">
<title>Author contributions</title>
<p>XY, XZ, LL, and GG conceptualized the study and analyzed the data. XY has carried out the bioinformatics assay. XY and LL revised the manuscript.</p>
</sec>
<sec id="s9">
<title>Funding</title>
<p>This work is supported by National Natural Science Foundation of China (82270051), Reform and Development Program of Beijing Institute of Respiratory Medicine (ysrh2022006).</p>
</sec>
<sec sec-type="COI-statement" id="s7">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s8">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Babalola</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Mamalis</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lev-Tov</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jagdeo</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>The role of microRNAs in skin fibrosis</article-title>. <source>Arch. Dermatol. Res.</source> <volume>305</volume> (<issue>9</issue>), <fpage>763</fpage>&#x2013;<lpage>776</lpage>. <comment>Epub 2013/09/12</comment>. <pub-id pub-id-type="doi">10.1007/s00403-013-1410-1</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berman</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Maderal</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Raphael</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Keloids and hypertrophic scars: Pathophysiology, classification, and treatment</article-title>. <source>Dermatol. Surg.</source> <volume>43</volume>, <fpage>S3</fpage>. <pub-id pub-id-type="doi">10.1097/DSS.0000000000000819</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Huo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Circ_0008450 downregulates Runx3 to promote the proliferation and epithelial-mesenchymal transition of human keratinized epithelial cells</article-title>. <source>Cell Cycle</source> <volume>19</volume> (<issue>23</issue>), <fpage>3303</fpage>&#x2013;<lpage>3316</lpage>. <comment>Epub 2020/11/03</comment>. <pub-id pub-id-type="doi">10.1080/15384101.2020.1842665</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>L. L.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The expanding regulatory mechanisms and cellular functions of circular RNAs</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source> <volume>21</volume> (<issue>8</issue>), <fpage>475</fpage>&#x2013;<lpage>490</lpage>. <comment>Epub 2020/05/06</comment>. <pub-id pub-id-type="doi">10.1038/s41580-020-0243-y</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Date</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Oncogenic RUNX3: A link between p53 deficiency and myc dysregulation</article-title>. <source>Mol. Cells</source> <volume>43</volume> (<issue>2</issue>), <fpage>176</fpage>&#x2013;<lpage>181</lpage>. <comment>Epub 2020/01/30</comment>. <pub-id pub-id-type="doi">10.14348/molcells.2019.0285</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Timoteo</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bozzoni</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Circular RNAs in cell differentiation and development</article-title>. <source>Development</source> <volume>147</volume> (<issue>16</issue>), <fpage>dev182725</fpage>. <comment>Epub 2020/08/26</comment>. <pub-id pub-id-type="doi">10.1242/dev.182725</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ekstein</surname>
<given-names>S. F.</given-names>
</name>
<name>
<surname>Wyles</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Moran</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Meves</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Keloids: A review of therapeutic management</article-title>. <source>Int. J. Dermatol.</source> <volume>60</volume> (<issue>6</issue>), <fpage>661</fpage>&#x2013;<lpage>671</lpage>. <comment>Epub 2020/09/10</comment>. <pub-id pub-id-type="doi">10.1111/ijd.15159</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fujita</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Atsumi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ohki</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>NEDD4 is involved in inflammation development during keloid formation</article-title>. <source>J. Invest. Dermatol.</source> <volume>139</volume> (<issue>2</issue>), <fpage>333</fpage>&#x2013;<lpage>341</lpage>. <comment>Epub 2018/10/03</comment>. <pub-id pub-id-type="doi">10.1016/j.jid.2018.07.044</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Circular RNA hsa_circ_0057452 facilitates keloid progression by targeting the microRNA-1225-3p/AF4/FMR2 family member 4 axis</article-title>. <source>Bioengineered</source> <volume>13</volume> (<issue>5</issue>), <fpage>13815</fpage>&#x2013;<lpage>13828</lpage>. <comment>Epub 2022/06/17</comment>. <pub-id pub-id-type="doi">10.1080/21655979.2022.2084460</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Alghamdi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fear</surname>
<given-names>M. W.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>From genetics to epigenetics: New insights into keloid scarring</article-title>. <source>Cell Prolif.</source> <volume>50</volume> (<issue>2</issue>), <fpage>e12326</fpage>. <comment>Epub 2017/01/06</comment>. <pub-id pub-id-type="doi">10.1111/cpr.12326</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeck</surname>
<given-names>W. R.</given-names>
</name>
<name>
<surname>Sorrentino</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Slevin</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Burd</surname>
<given-names>C. E.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Circular RNAs are abundant, conserved, and associated with ALU repeats</article-title>. <source>RNA</source> <volume>19</volume> (<issue>2</issue>), <fpage>141</fpage>&#x2013;<lpage>157</lpage>. <comment>Epub 2012/12/20</comment>. <pub-id pub-id-type="doi">10.1261/rna.035667.112</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>CircCOL5A1 inhibits proliferation, migration, invasion, and extracellular matrix production of keloid fibroblasts by regulating the miR-877-5p/EGR1 axis</article-title>. <source>Burns</source> <volume>2022</volume>, <fpage>35184918</fpage>. <pub-id pub-id-type="doi">10.1016/j.burns.2021.12.013</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kristensen</surname>
<given-names>L. S.</given-names>
</name>
<name>
<surname>Andersen</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Stagsted</surname>
<given-names>L. V. W.</given-names>
</name>
<name>
<surname>Ebbesen</surname>
<given-names>K. K.</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>T. B.</given-names>
</name>
<name>
<surname>Kjems</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The biogenesis, biology and characterization of circular RNAs</article-title>. <source>Nat. Rev. Genet.</source> <volume>20</volume> (<issue>11</issue>), <fpage>675</fpage>&#x2013;<lpage>691</lpage>. <comment>Epub 2019/08/10</comment>. <pub-id pub-id-type="doi">10.1038/s41576-019-0158-7</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Highthroughput sequencing reveals differentially expressed lncRNAs and circRNAs, and their associated functional network, in human hypertrophic scars</article-title>. <source>Mol. Med. Rep.</source> <volume>18</volume> (<issue>6</issue>), <fpage>5669</fpage>&#x2013;<lpage>5682</lpage>. <comment>Epub 2018/10/16</comment>. <pub-id pub-id-type="doi">10.3892/mmr.2018.9557</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname>
<given-names>Z. Z.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T. T.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>circRNA-miRNA-mRNA regulatory network in human lung cancer: an update</article-title>. <source>Cancer Cell Int.</source> <volume>20</volume>, <fpage>173</fpage>. <comment>Epub 2020/05/30</comment>. <pub-id pub-id-type="doi">10.1186/s12935-020-01245-4</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Limandjaja</surname>
<given-names>G. C.</given-names>
</name>
<name>
<surname>Niessen</surname>
<given-names>F. B.</given-names>
</name>
<name>
<surname>Scheper</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Gibbs</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The keloid disorder: Heterogeneity, histopathology, mechanisms and models</article-title>. <source>Front. Cell Dev. Biol.</source> <volume>8</volume>, <fpage>360</fpage>. <comment>Epub 2020/06/13</comment>. <pub-id pub-id-type="doi">10.3389/fcell.2020.00360</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhan</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Silencing circular RNAPTPN12 promoted the growth of keloid fibroblasts by activating Wnt signaling pathway via targeting microRNA-21-5p</article-title>. <source>Bioengineered</source> <volume>13</volume> (<issue>2</issue>), <fpage>3503</fpage>&#x2013;<lpage>3515</lpage>. <comment>Epub 2022/01/25</comment>. <pub-id pub-id-type="doi">10.1080/21655979.2022.2029108</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ni</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Circular RNA hsa_circ_0043688 serves as a competing endogenous RNA for microRNA-145-5p to promote the progression of Keloids via Fibroblast growth factor-2</article-title>. <source>J. Clin. Lab. Anal.</source> <volume>36</volume>, <fpage>e24528</fpage>. <comment>Epub 2022/06/28</comment>. <pub-id pub-id-type="doi">10.1002/jcla.24528</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lv</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Circular RNA CircCOL5A1 sponges the MiR-7-5p/epac1 Axis to promote the progression of keloids through regulating PI3K/akt signaling pathway</article-title>. <source>Front. Cell Dev. Biol.</source> <volume>9</volume>, <fpage>626027</fpage>. <comment>Epub 2021/02/09</comment>. <pub-id pub-id-type="doi">10.3389/fcell.2021.626027</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lv</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Epigenetic modification mechanisms involved in keloid: Current status and prospect</article-title>. <source>Clin. Epigenetics</source> <volume>12</volume> (<issue>1</issue>), <fpage>183</fpage>. <comment>Epub 2020/11/28</comment>. <pub-id pub-id-type="doi">10.1186/s13148-020-00981-8</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Memczak</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jens</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Elefsinioti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Torti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Krueger</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rybak</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Circular RNAs are a large class of animal RNAs with regulatory potency</article-title>. <source>Nature</source> <volume>495</volume> (<issue>7441</issue>), <fpage>333</fpage>&#x2013;<lpage>338</lpage>. <comment>Epub 2013/03/01PubMed PMID: 23446348</comment>. <pub-id pub-id-type="doi">10.1038/nature11928</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olaitan</surname>
<given-names>P. B.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Keloids: Assessment of effects and psychosocial-impacts on subjects in a black african population</article-title>. <source>Indian J. dermatol. Venereol. Leprol.</source> <volume>75</volume> (<issue>4</issue>), <fpage>368</fpage>&#x2013;<lpage>372</lpage>. <comment>Epub 2009/07/09</comment>. <pub-id pub-id-type="doi">10.4103/0378-6323.53132</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Comprehensive analysis of circular RNA expression in ceRNA networks and identification of the effects of hsa_circ_0006867 in keloid dermal fibroblasts</article-title>. <source>Front. Mol. Biosci.</source> <volume>9</volume>, <fpage>800122</fpage>. <pub-id pub-id-type="doi">10.3389/fmolb.2022.800122</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>T. H.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>C. H.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Are auricular keloids and persistent hypertrophic scars resectable? The role of intrascar excision</article-title>. <source>Ann. Plast. Surg.</source> <volume>72</volume> (<issue>3</issue>), <fpage>369</fpage>. <comment>Epub 2013/05/10</comment>. <pub-id pub-id-type="doi">10.1097/SAP.0b013e31827f5131</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakshi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jayasuriya</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ganesan</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ramkumar</surname>
<given-names>K. M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Role of circRNA-miRNA-mRNA interaction network in diabetes and its associated complications</article-title>. <source>Mol. Ther. Nucleic Acids</source> <volume>26</volume>, <fpage>1291</fpage>&#x2013;<lpage>1302</lpage>. <comment>Epub 2021/12/03</comment>. <pub-id pub-id-type="doi">10.1016/j.omtn.2021.11.007</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanger</surname>
<given-names>H. L.</given-names>
</name>
<name>
<surname>Klotz</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Riesner</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Kleinschmidt</surname>
<given-names>A. K.</given-names>
</name>
</person-group> (<year>1976</year>). <article-title>Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>73</volume> (<issue>11</issue>), <fpage>3852</fpage>&#x2013;<lpage>3856</lpage>. <comment>Epub 1976/11/01</comment>. <pub-id pub-id-type="doi">10.1073/pnas.73.11.3852</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>The integrative regulatory network of circRNA and microRNA in keloid scarring</article-title>. <source>Mol. Biol. Rep.</source> <volume>47</volume> (<issue>1</issue>), <fpage>201</fpage>&#x2013;<lpage>209</lpage>. <comment>Epub 2019/10/16</comment>. <pub-id pub-id-type="doi">10.1007/s11033-019-05120-y</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Khumalo</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bayat</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Understanding keloid pathobiology from a quasi-neoplastic perspective: Less of a scar and more of a chronic inflammatory disease with cancer-like tendencies</article-title>. <source>Front. Immunol.</source> <volume>10</volume>, <fpage>1810</fpage>. <comment>Epub 2019/08/24</comment>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.01810</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vo</surname>
<given-names>J. N.</given-names>
</name>
<name>
<surname>Cieslik</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shukla</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>The landscape of circular RNA in cancer</article-title>. <source>Cell</source> <volume>176</volume> (<issue>4</issue>), <fpage>869</fpage>&#x2013;<lpage>881</lpage>. <comment>e13Epub 2019/02/09</comment>. <pub-id pub-id-type="doi">10.1016/j.cell.2018.12.021</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>circNRIP1 facilitates keloid progression via FXR1mediated upregulation of miR5033p and miR5035p</article-title>. <source>Int. J. Mol. Med.</source> <volume>47</volume> (<issue>5</issue>), <fpage>70</fpage>. <comment>Epub 2021/03/03</comment>. <pub-id pub-id-type="doi">10.3892/ijmm.2021.4903</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Expression profiles of lncRNAs and circRNAs in keloid</article-title>. <source>Plast. Reconstr. Surg. Glob. Open</source> <volume>7</volume> (<issue>6</issue>), <fpage>e2265</fpage>. <comment>Epub 2019/10/19</comment>. <pub-id pub-id-type="doi">10.1097/GOX.0000000000002265</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>CircPDE7B/miR-661 axis accelerates the progression of human keloid fibroblasts by upregulating fibroblast growth factor 2 (FGF2)</article-title>. <source>Mol. Cell. Biochem.</source> <volume>477</volume> (<issue>4</issue>), <fpage>1113</fpage>&#x2013;<lpage>1126</lpage>. <comment>Epub 2022/01/27</comment>. <pub-id pub-id-type="doi">10.1007/s11010-021-04345-5</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Effects of the circ_101238/miR-138-5p/CDK6 axis on proliferation and apoptosis keloid fibroblasts</article-title>. <source>Exp. Ther. Med.</source> <volume>20</volume> (<issue>3</issue>), <fpage>1995</fpage>&#x2013;<lpage>2002</lpage>. <comment>Epub 2020/08/13</comment>. <pub-id pub-id-type="doi">10.3892/etm.2020.8917</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>CircSLC8A1 targets miR-181a-5p/HIF1AN pathway to inhibit the growth, migration and extracellular matrix deposition of human keloid fibroblasts</article-title>. <source>Burns</source> <volume>2022</volume>, <fpage>35610079</fpage>. <pub-id pub-id-type="doi">10.1016/j.burns.2022.04.009</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X. F.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z. C.</given-names>
</name>
<name>
<surname>Lou</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>Q. Q.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y. Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Current potential therapeutic strategies targeting the TGF-&#x3b2;/Smad signaling pathway to attenuate keloid and hypertrophic scar formation</article-title>. <source>Biomed. Pharmacother. &#x3d; Biomedecine Pharmacother.</source> <volume>129</volume>, <fpage>110287</fpage>. <comment>Epub 2020/06/17</comment>. <pub-id pub-id-type="doi">10.1016/j.biopha.2020.110287</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Expression profile and bioinformatics analyses of circular RNAs in keloid and normal dermal fibroblasts</article-title>. <source>Exp. Cell Res.</source> <volume>388</volume> (<issue>1</issue>), <fpage>111799</fpage>. <comment>Epub 2020/01/07</comment>. <pub-id pub-id-type="doi">10.1016/j.yexcr.2019.111799</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhai</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Circ_0057452 sponges miR-7-5p to promote keloid progression through upregulating GAB1</article-title>. <source>Cell cycle</source>, <fpage>1</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1080/15384101.2022.2102796</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>